C. Chastang

C. Chastang, C. Jacquillat, J. Maral, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Needle biopsy of hepatocellular carcinoma: Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes

C. Chastang, J. Trinchet, M. Beaugrand, 1996, Cancer.

Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non‐small cell carcinoma results from a randomized phase II trial

J. Benichou, B. Dautzenberg, C. Chastang, 1990, Cancer.

Syndrome de Guillain-Barr. Aspects cliniques et thrapeutiques rcents

S. Chevret, C. Chastang, M. Jars-Guincestre, 1991 .

Efficacy of 2‐month total parenteral nutrition in AIDS patients: a controlled randomized prospective trial

C. Chastang, F. Carbonnel, B. Messing, 1996, AIDS.

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

C. Chastang, F. Locatelli, E. Gluckman, 1997, The New England journal of medicine.

Long-term efficacy of a new, fixed, very-low-dose-ace-inhibitor/diuretic combination at first line therapy in elderly hypertensive patients

A. Castaigne, C. Chastang, T. Morgan, 2000 .

Prevalence of magnesium and potassium deficiencies in the elderly.

C. Chastang, Y. Touitou, A. Bogdan, 1987, Clinical chemistry.

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia

C. Chastang, F. Locatelli, E. Gluckman, 2016 .

Salmeterol compared with slow‐release terbutaline in nocturnal asthma A multicenter, randomized, double‐blind, double‐dummy, sequential clinical trial

C. Chastang, C. Brambilla, L. Bertin, 1994, Allergy.

Adjvant treatment of tongue and floor of the mouth cancers.

C. Chastang, J. Bertrand, H. Szpirglas, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Incidence and causes of carbon monoxide intoxication: results of an epidemiologic survey in a French department.

S. Chevret, C. Chastang, J. Pasteyer, 1991, Archives of environmental health.

Clinical presentation, prognostic factors, and outcome of ARDS in the European Collaborative Study (1985-1987)

L. Blanch, C. Chastang, R. Fernandez, 1991 .

Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials

E. Kimby, F. Bosch, E. Montserrat, 1999 .

Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis

S. Chevret, C. Chastang, B. Clair, 1997 .

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation.

J. Latgé, C. Chastang, F. Derouin, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Designing a study for evaluating a protocol for the selective performance of preoperative tests.

C. Chastang, Y. Charpak, C. Blery, 1987, Statistics in medicine.

An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.

B. Milleron, C. Chastang, D. Moro, 1994, Seminars in oncology.

Plasma Exchange and Guillian-Barré Syndrome

S. Chevret, C. Chastang, J. Raphael, 1991 .

Plasma exchange morbidity in Guillain‐Barré syndrome: Results from the French prospective, double‐blind, randomized, multicenter study

S. Chevret, C. Chastang, J. Raphael, 1993 .

Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial.

C. Chastang, F. Derouin, C. Sarfati, 1998, The Journal of infectious diseases.

Determinants of spontaneous occurrence of sustained monomorphic ventricular tachycardia in right ventricular dysplasia.

P. Coumel, C. Chastang, P. Maison-Blanche, 1996, Journal of the American College of Cardiology.

A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia.

C. Chastang, L. Holzapfel, J. Bohé, 1999, American journal of respiratory and critical care medicine.

Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group.

C. Chastang, P. Fenaux, L. Degos, 1994, Leukemia.

Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.

C. Chastang, M. Fey, P. Fenaux, 1995, Leukemia & lymphoma.

Factors Influencing Outcome in De Novo Myelodysplastic Syndromes Treated by Allogeneic Bone Marrow Transplantation: A Long-Term Study

C. Chastang, X. Troussard, N. Ifrah, 2002 .

Treatment of early AIDS‐related Kaposi's sarcoma with oral all‐trans‐retinoic acid: results of a sequential non‐randomized phase II trial

C. Chastang, J. Nicolas, P. Saiag, 1998, AIDS.

Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia

C. Chastang, P. Fenaux, C. Chomienne, 1994, The Lancet.

New trends in CLL treatment.

C. Chastang, J. Binet, G. Dighiero, 1987, Blood cells.

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

Marie-Cécile Michallet, Bruno Lioure, C. Chastang, 1996 .

Continuous infusion of high-dose metoclopramide: comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis

C. Chastang, J. Laaban, J. Dupeyron, 2004, European Journal of Clinical Pharmacology.

Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.

J. Tuomilehto, B. Williams, P. Amouyel, 2003, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.

T. Hedner, D. Duprez, C. Chastang, 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults.

C. Chastang, Y. Charpak, G. Tobelem, 1988, Blood.

Allogeneic Cord Blood Hematopoietic Stem Cell Transplants in Malignancies

C. Chastang, E. Gluckman, V. Rocha, 2000 .

Umbilical Cord Blood Hematopoietic Stem Cell Transplantation

C. Chastang, E. Gluckman, V. Rocha, 1999 .

Cord Blood Transplantation in Hematopoietic Malignancies

C. Chastang, E. Gluckman, V. Rocha, 1998 .

A Study of the Agreement of Medical Information Application to Histological Slide Readings in Chronic Lymphocytic Leukemia

J. Diebold, F. Grémy, A. Auquier, 1982 .

Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients.

S. Chevret, C. Chastang, J. Carlet, 1997, The Journal of rheumatology.

[Sequential analysis of randomized therapeutic trials in which the judgment criterion is survival. Use of the triangular test].

J. Benichou, C. Chastang, 1987, Therapie.

Cord Blood Banking and Transplant in Europe

C. Chastang, E. Gluckman, V. Rocha, 1998 .

Patient accrual and interim statistical analysis in long-term randomized clinical trials: the French chronic lymphocytic leukemia CLL 80 protocol as a case study.

J. Benichou, C. Chastang, J. Binet, 1986, Statistics in medicine.

Cord blood stem cell transplantation

C. Chastang, E. Gluckman, V. Rocha, 1999 .

[Estimation by the Hui and Walter method of the sensitivity and specificity of a diagnostic test in the absence of a reference test: results of a simulation study].

J. Benichou, C. Chastang, P. Bertrand, 1994, Revue d'epidemiologie et de sante publique.

A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma

C. Chastang, B. Lebeau, T. Urban, 1999 .

HYPERBARIC OXYGEN FOR CARBON MONOXIDE POISONING

C. Piantadosi, C. Chastang, J. Raphael, 1989, The Lancet.

An equivalence study of the safety and efficacy of a fixed‐dose combination of perindopril with indapamide versus fixed‐dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension

C. Chastang, D. Guez, Y. Brault, 1995, Journal of hypertension.

Subcutaneous heparin treatment increases survival in small cell lung cancer

E. Lemarié, C. Chastang, F. Capron, 1994, Cancer.

Predictive Factors for Failure of Isotretinoin Treatment in Acne Patients: Results from a Cohort of 237 Patients

C. Chastang, P. de la Salmonière, P. Morel, 1999, Dermatology.

Short therapy with amoxicillin-clavulanate and corticosteroids in acute sinusitis: results of a multicentre study in adults.

A Desaulty, C Beauvillain, C Chastang, 2000, Scandinavian journal of infectious diseases.

TRIAL OF NORMOBARIC AND HYPERBARIC OXYGEN FOR ACUTE CARBON MONOXIDE INTOXICATION

C. Chastang, J. Raphael, M. Jars-Guincestre, 1989, The Lancet.

Acute carbon monoxide intoxication and hyperbaric oxygen in pregnancy

C. Chastang, J. Raphaël, J. Raphael, 2005, Intensive Care Medicine.

Controlled study of malathion and d-phenothrin lotions for Pediculus humanus var capitis-infested schoolchildren

Mohand, C. Chastang, O. Chosidow, 1994, The Lancet.

Dermatologic findings in HIV-1-infected patients: a prospective study with emphasis on CD4+ cell count.

C. Chastang, P. Morel, C. Rabian, 1996, Dermatology.

Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine

C. Chastang, F. Derouin, J. Pocidalo, 1991, Antimicrobial Agents and Chemotherapy.

Clinical Trial of Plasma Exchange and High-dose Intravenous Irnrnunodobulin in Mvasthenia Gravis

S. Chevret, C. Chastang, B. Clair, 2022 .

Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection

C. Chastang, F. Derouin, L. Cotte, 2000, AIDS.

Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study

C. Katlama, C. Chastang, F. Raffi, 1997, AIDS.

Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group.

F Locatelli, C Chastang, C. Chastang, 1999, Blood.

Outcome of cord-blood transplantation from related and unrelated donors

C. Chastang, F. Locatelli, E. Gluckman, 1997 .

Prevalence and Risk Factors for Carriage of Methicillin-Resistant Staphylococcus aureus at Admission to the Intensive Care Unit

S. Chevret, C. Chastang, I. Durand-zaleski, 2016 .

Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1·5 mm without clinically detectable node metastases

C. Chastang, J. Grob, B. Dréno, 1998, The Lancet.

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.

C Chastang, R. Bouabdallah, C. Chastang, 1997, The New England journal of medicine.

Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients.

S. Chevret, C. Chastang, J. Bréchot, 1997, European journal of cancer.

Adjuvant immunotherapy with nonviable mycobacterium smegmatis in resected primary lung carcinoma a randomized clinical trial of 219 patients

F. Grémy, C. Chastang, B. Asselain, 1984, Cancer.

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.

R. Bouabdallah, H. Dombret, F. Mandelli, 1995, The New England journal of medicine.

White blood cell count: a prognostic factor and possible subset indicator of optimal treatment with low-dose adjuvant interferon in primary melanoma.

C. Chastang, J. Grob, B. Dréno, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Reinforced regiment of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomized trial

S. Chevret, C. Chastang, P. Chaumet‐Riffaud, 1998 .

A double-blind, randomized study assessing the equivalence of valacyclovir 1000 mg once daily versus 500 mg twice daily in the episodic treatment of recurrent genital herpes

C. Chastang, P. Saiag, D. Praindhui, 1999 .

Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

J. Miguel, H. Dombret, C. Chastang, 1998 .

Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.

J. Miguel, H. Dombret, C. Chastang, 1998, Blood.

Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis

C. Chastang, M. Sibony, N. Ganne-Carrié, 1996, Hepatology.

Letter to Dermatology

L. Thomas, A. Schindl, M. Schindl, 1999, Dermatology.

Therapy in Newly Diagnosed Acute Promyelocytic Leukemia Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by

J. Miguel, H. Dombret, A. Stamatoullas, 2014 .

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.

J. Miguel, H. Dombret, A. Stamatoullas, 1999, Blood.

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

H. Dombret, C. Chastang, P. Fenaux, 1995, Blood.

Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase II nonrandomized study.

C. Chastang, F. Goffinet, I. Nisand, 1998, American journal of obstetrics and gynecology.

Phase I-II trial of Seraspenide (AcSDKP): a supressor of myelopoiesis protects against chemotherapy myelotoxicity (version 10 february 1993)

A. Vekhoff, C. Chastang, D. Khayat, 1994 .

Six vs twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial. The "Petites Cellules" Group.

C. Chastang, P. Allard, B. Lebeau, 1992, The European respiratory journal.

Chemotherapy–radiotherapy association in Hodgkin's Disease, clinical stages IA, II2A: Results of a prospective clinical trial with 166 patients

C. Chastang, B. Asselain, B. Montagnon, 1980, Cancer.

Comparison of digital and ultrasonographic examination of the cervix in predicting time interval from induction to delivery in women with a low Bishop score

Y. Ville, S. Chevret, C. Chastang, 2005, BJOG : an international journal of obstetrics and gynaecology.

Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: Correlation with TNM stage and disease free and overall survival

S. Chevret, C. Chastang, F. Capron, 1996, Cancer.

Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study

M. Ziol, C. Chastang, N. Ganne-Carrié, 2000, Gut.

GUILLAIN-BARRÉ SYNDROME AND PLASMA EXCHANGE

C. Chastang, J. Raphael, M. Goulon, 1985, The Lancet.

Prognostic value of early computed tomographic scans in severe acute pancreatitis. French Association for Surgical Research.

D. Mathieu, S. Chevret, C. Chastang, 1994, Journal of the American College of Surgeons.

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial.

E. Lemarié, B. Milleron, C. Chastang, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomised clinical trial comparing interferon-α and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM

C. Chastang, X. Mariette, P. Clavelou, 1997 .

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.

E. Lemarié, B. Milleron, L. Thiberville, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases.

C. Chastang, N. Brousse, J. Bernard, 1984, Blood.

Cord blood transplantation for children with acute leukemia. Eurocord Transplant Group.

C. Chastang, F. Locatelli, P. Comoli, 1998, Bone Marrow Transplantation.

Cord blood transplantation for children with acute leukemia

C. Chastang, F. Locatelli, P. Comoli, 1998 .

CD 1 c is not a feature of mixed‐cell type but of a typical form of chronic lymphocytic leukaemia

P. Debré, C. Chastang, J. Binet, 1992, European journal of haematology.

Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.

S. Chevret, C. Chastang, H. Merle-Béral, 1996, Blood.

Long term results of an adjuvant therapy with low doses IFN-??2A in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases: 113

C. Chastang, L. Thill, B. Dréno, 1997 .

Long‐term efficacy of a new, fixed, very‐low‐dose angiotensin‐converting enzyme‐inhibitor/diuretic combination as first‐line therapy in elderly hypertensive patients

A. Castaigne, C. Chastang, T. Morgan, 2000, Journal of hypertension.

The addition of cisplatin to cyclophosphamide‐doxorubicin‐etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma

C. Chastang, B. Lebeau, T. Urban, 1999, Cancer.

Standard combination versus alternating chemotherapy in small cell lung cancer: a randomised clinical trial including 394 patients. 'Petites Cellules' Group.

C. Chastang, B. Lebeau, T. Urban, 1999, Lung cancer.

Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma.

S. Chevret, C. Chastang, A. de Roquancourt, 2003, Human pathology.

Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma.

C. Chastang, J. Grob, B. Dréno, 1998, Lancet.

Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture

C. Chastang, F. Derouin, 1988, Antimicrobial Agents and Chemotherapy.

Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia.

C. Chastang, S. Baudet, O. Tournilhac, 2000, The hematology journal : the official journal of the European Haematology Association.

Adjuvant chemotherapy in the management of primary malignant melanoma

C. Chastang, C. Jacquillat, M. Weil, 1978 .

Lymph node involvement as the only prognostic factor in curative resected gastric carcinoma: A multivariate analysis

S. Msika, C. Chastang, F. Lacaine, 2005, World Journal of Surgery.

Pathology Underrates Colon Cancer Extranodal and Nodal Metastases; Ex vivo Radioimmunodetection Helps Staging

A. Sézeur, C. Chastang, J. Talbot, 2007, Clinical Cancer Research.

Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.

C. Chastang, A. Monnier, Y. Chrétien, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phenotypic heterogeneity of B‐ and T‐cell differentiation antigens in B‐CLL

P. Debré, C. Chastang, C. Blanc, 1988, European journal of haematology.

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma.

S. Chevret, C. Chastang, M. Beaugrand, 1995, The New England journal of medicine.

Diagnostic and prognostic significance of myelomonocytic cell surface antigens in acute myeloid leukaemia

C. Chastang, V. Leblond, C. Boucheix, 1989, British journal of haematology.

A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.

C. Chastang, X. Mariette, P. Clavelou, 1997, Journal of neurology, neurosurgery, and psychiatry.

Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma.

P. Gaulard, C. Chastang, N. Brousse, 1987, The American journal of medicine.

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle.

C. Chastang, J. Reiffers, X. Troussard, 1996, Blood.

In vitro effects of folate inhibitors on Toxoplasma gondii

C. Chastang, F. Derouin, Francis DEROUINl, 1989, Antimicrobial Agents and Chemotherapy.

Proposals for a Phenotypic Classification of B-Chronic Lymphocytic Leukemia, Relationship with Prognostic Factors.

P. Debré, C. Chastang, J. Binet, 1991, Leukemia & lymphoma.

A simulation study of three sequential methods for the comparison of two treatment groups when the response criterion is censored.

J. Benichou, C. Chastang, 1986, Statistics in medicine.

Effectiveness of ribosomal fractions ofKlebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction ofKp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis

P. Cauwenberge, C. Chastang, J. Demanez, 1997, European Archives of Oto-Rhino-Laryngology.

Effects of brief early exposure to partially hydrolyzed and whole cow milk proteins.

C. Chastang, P. Robillard, S. Strobel, 1992, The Journal of pediatrics.

Plasma Exchange and Intravenous Immunoglobulin in Autoimmune Myasthenia Gravis a

S. Chevret, C. Chastang, B. Clair, 1998 .

Community-acquired pneumonia in the ICU.

S. Chevret, C. Chastang, P. Moine, 1995 .

Peripheral stem cells in bone marrow transplantation. Cord blood stem cell transplantation.

C. Chastang, E. Gluckman, V. Rocha, 1999, Bailliere's best practice & research. Clinical haematology.

Male Urethritis with and Without Discharge: A Clinical and Microbiological Study

C. Chastang, P. Morel, I. Casin, 1995, Sexually transmitted diseases.

A Prospective Study of the Influence of HIV Status on the Seroreversion of Serological Tests for Syphilis

C. Chastang, P. Morel, C. Rabian, 1999, Dermatology.

Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis.

C. Chastang, M. Boudiaf, D. Elkharrat, 1999, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[Microbiological study of male genital ulcers. Apropos of 75 cases].

C. Chastang, P. Morel, I. Casin, 1990, Pathologie-biologie.

Assessing smallest detectable change over time in continuous structural outcome measures: application to radiological change in knee osteoarthritis.

M. Dougados, P. Ravaud, B. Giraudeau, 1999, Journal of clinical epidemiology.

A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study

C. Chastang, J. Emeriau, G. Leonetti, 2001, Journal of hypertension.

Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study

P. Gosse, J. Degaute, F. Zannad, 2000, Journal of hypertension.

Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy

S. Chevret, C. Chastang, J. Raphael, 1994, The Lancet.

Early predictors of outcome for HIV patients with neurological failure.

C. Chastang, J. Lucet, M. Wolff, 1995, JAMA.

Analysis of phase II clinical trials in haematology and oncology: comparison of the triangular test to the usual methods.

J. Benichou, C. Chastang, É. Bellissant, 1991, Statistics in medicine.

160 children, 223 adults thrombocytopenic purpura (ITP): results of a randomized clinical trial in Low doses v conventional doses of corticoids in immune

C. Chastang, Y. Charpak, G. Tobelem, 2011 .

[Evaluation of a protocol for selective ordering of preoperative tests in healthy subjects].

C. Chastang, Y. Charpak, C. Blery, 1986, Annales francaises d'anesthesie et de reanimation.

A randomized trial of delayed thoracic radiotherapy in complete responder patients with small-cell lung cancer. Petites Cellules Group.

C. Chastang, F. Capron, B. Lebeau, 1993, Chest.

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

S. Chevret, C. Chastang, M. Beaugrand, 1999, Journal of hepatology.

DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction.

R. Porcher, S. Chevret, C. Chastang, 2004, European heart journal.

Usefulness of Selectively Ordered Preoperative Tests

C. Chastang, Y. Charpak, C. Blery, 1988, Medical care.

A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma

R. Arriagada, B. Dautzenberg, C. Chastang, 1999, Cancer.

Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis.

C Chastang, P Grenier, S Chevret, 1994, Radiology.

[Inoperable primary bronchial cancers: treatment by chemotherapy combinations including cis-platinum].

C. Chastang, D. Belpomme, H. Gautier, 1983, Presse medicale.

Use of the triangular test in the analysis of randomized clinical trials when the response criterion is censored: application to two trials in lung cancer.

J. Benichou, C. Chastang, 1988, Antibiotics and chemotherapy.

Statistical properties and use of sequential methods in randomized clinical trials when the response criterion is censored.

J. Benichou, C. Chastang, 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

A microcomputer program for the design and analysis of phase II cancer clinical trials with two group sequential methods, the sequential probability ratio test, and the triangular test.

J. Benichou, C. Chastang, É. Bellissant, 1994, Computers and biomedical research, an international journal.

Misconceptions about nasal ventilation

S. Chevret, C. Chastang, J. Bach, 1994, The Lancet.

Outcome of patients with systemic rheumatic disease admitted to medical intensive care units.

C. Chastang, J. Dhainaut, F. Brunet, 1992, Annals of the rheumatic diseases.

Prognostic Significance of Supraclavicular Lymph Nodes in Small Cell Lung Cancer: A Study From Four Consecutive Clinical Trials, Including 1,370 Patients

C. Chastang, F. Vaylet, B. Lebeau, 1998 .

A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.

C. Chastang, B. Lebeau, T. Urban, 1999, Cancer.

[Long-term study of 416 cases of Parkinson disease. Prognostic factors and therapeutic implications].

C. Chastang, G. Fénelon, A. Guillard, 1986, Revue neurologique.

Is bone marrow biopsy a prognostic parameter in B-CLL?

C. Chastang, M. Raphael, J. Binet, 1988, Nouvelle revue francaise d'hematologie.

Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis

M. Dougados, B. Giraudeau, C. Chastang, 1998, Annals of the rheumatic diseases.

Radiographic assessment of knee osteoarthritis: reproducibility and sensitivity to change.

M. Dougados, P. Ravaud, B. Giraudeau, 1996, The Journal of rheumatology.

Comment on Quan and Shih's "Assessing reproducibility by the within-subject coefficient of variation with random effects models".

P. Ravaud, B. Giraudeau, C. Chastang, 2000, Biometrics.

No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy results from a randomized clinical trial of 303 patients

C. Chastang, F. Massin, B. Lebeau, 1993, Cancer.

[Treatment of Guillain-Barré syndrome by plasma exchange: proposal of a therapeutic strategy].

S. Chevret, C. Chastang, J. Raphael, 1996, Revue neurologique.

C. Chastang, F. Locatelli, A. Nagler, 1998, Bone marrow transplantation.

Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine.

C. Chastang, F. Derouin, 1990, The Journal of antimicrobial chemotherapy.

Impact of guidelines to alter antitetanus prophylaxis practices and reduce costs in the emergency department.

C. Chastang, I. Durand-zaleski, D. Elkharrat, 1999, American journal of therapeutics.

Effects of Spinal Cord X-irradiation on the Recovery of Paraplegic Rats

J. Mallet, B. Giraudeau, C. Chastang, 2000, Experimental Neurology.

Sphincter-saving resection, or not, for cancer of the midrectum.

S. Chevret, C. Chastang, S. Houry, 1997, American journal of surgery.

[Assessment of the quality of life of cancer patients. The preliminary applications to advanced bronchial cancers].

B. Dautzenberg, C. Chastang, J. Bernheim, 1986, Bulletin du cancer.

Cord blood banking and transplant in Europe. Eurocord.

C. Chastang, E. Gluckman, V. Rocha, 1998, Bone marrow transplantation.

Cord blood banking and transplant in Europe. Eurocord.

C. Chastang, E. Gluckman, V. Rocha, 1998, Vox sanguinis.

Plasma exchange morbidity in Guillain-Barré syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group.

S. Chevret, C. Chastang, J. Raphael, 1993, Critical care medicine.

A short induction regimen of interferon‐α is not effective for treatment of relapse in chronic hepatitis C: a randomized trial

S. Chevret, C. Chastang, M. Vidaud, 1999 .

Septic shock in patients with the acquired immunodeficiency syndrome

B. Souweine, C. Chastang, B. Régnier, 1997, Intensive Care Medicine.

EFFICACY AND SAFETY OF AN ORAL FIXED LOW-DOSE PERINDOPRIL 2 MGDNDAPAMIDE 0.625 MG COMBINATION: STUDY IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED

A. Castaigne, C. Chastang, D. Guez, 1999 .

The group sequential triangular test for phase II cancer clinical trials.

J. Benichou, C. Chastang, É. Bellissant, 1996, American journal of clinical oncology.

Assessment of joint space width in patients with osteoarthritis of the knee: a comparison of 4 measuring instruments.

M. Dougados, H. Genant, P. Ravaud, 1996, The Journal of rheumatology.

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group.

A. Ganser, C. Chastang, M. Fey, 1993, Blood.

First interim analysis of a randomised clinical trial comparing plasma exchange and intravenous immunoglobulin in myasthenia gravis

F. Bolgert, C. Chastang, B. Eymard, 1994, Neuromuscular Disorders.

Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension.

A. Castaigne, C. Chastang, J. Chalmers, 1999, Clinical and experimental hypertension.

[Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies].

A. Vekhoff, C. Chastang, J. Ferrero, 1992, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non‐small cell carcinoma results from a randomized phase II trial

J. Benichou, B. Dautzenberg, C. Chastang, 1990, Cancer.

Phase III randomized study of Neo-Adjuvant chemotherapy surgery in non-small cell lung cancer (NSCLC) preliminary results

E. Lemarié, B. Milleron, C. Chastang, 1994 .

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.

S. Chevret, C. Chastang, B. Clair, 1997, Annals of Neurology.

Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study

M. Ziol, C. Chastang, N. Ganne-Carrié, 2000, Gut.

Pharmacology and Treatment Maintenance treatment of psoriasis by Tigason: a double‐blind randomized clinical trial

C. Chastang, L. Dubertret, J. Bazex, 1985 .

Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study.

S. Chevret, C. Chastang, I. Durand-zaleski, 2003, Archives of internal medicine.

Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis

M. Dougados, B. Giraudeau, C. Chastang, 1998, Annals of the rheumatic diseases.

Importance of Reproducibility in Responsiveness Issues

P. Ravaud, B. Giraudeau, C. Chastang, 1998 .

[Long-term prognostic factors in Parkinson's disease (author's transl)].

C. Chastang, A. Guillard, 1978, Revue neurologique.

Dose effect relationship of reviparin in chronic hemodialysis: a crossover study versus nadroparin.

J. Soria, C. Chastang, A. Baumelou, 2001, Artificial organs.